Tag Archives: Treos Bio

BIOTECH

Treos Bio Announces First Patient Dosed in Phase 2 Trial of PolyPEPI1018 in Combination with Roche’s PD-L1-Inhibitor for the Treatment of Metastatic Colorectal Cancer

LONDON, June 27, 2022 (GLOBE NEWSWIRE) — Treos Bio Limited (“Treos”), a clinical stage biotechnology...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.